Products

Empagliflozin Antidiabetic Human Use Factory Price CAS 864070 -44-0

China Empagliflozin Antidiabetic Human Use Factory Price CAS 864070-44-0, Find details about China Pharmaceutical Chemical, Medicine from Empagliflozin Antidiabetic Human Use Factory Price CAS 864070-44-0

Model NO.
ldswkj1-2-6
Trademark
Lingding
Transport Package
Carbon Capsule
Specification
10, 5, 2CM
Origin
China, Hebei
Model NO.
ldswkj1-2-6
Trademark
Lingding
Transport Package
Carbon Capsule
Specification
10, 5, 2CM
Origin
China, Hebei

Company Introduction

     Hebei Lingding Biotechnology Co., Ltd. is a professional business company ,that include pharmaceutical raw materials, pharmaceutical intermediates, and other more than 1000 products of the enterprise,  The registered capital is 3 million yuan, it is a collection of scientific research, production and sales in one of the enterprises.
     Since its establishment, the company has always adhered to the core concept of "focus on products, attentive service", adhere to the business purpose of "innovation, professional, win-win", to provide customers with a full range of meticulous and thoughtful services. We will adhere to the customer's serious and responsible attitude, comply with the standardized operation procedures, with efficient execution to complete customer needs.
     The company's products are sold all over the world, mainly exported to the United States, Europe, Southeast Asia, Australia, the Middle East and South Africa and other countries. The company has a strong scientific research and technical team, can provide customers with high quality products and a full range of services. We will provide first-class products and better service to face the needs of customers, to meet the challenges of the market.  Welcome domestic and foreign customers to negotiate.
Empagliflozin Antidiabetic Human Use Factory Price CAS 864070-44-0

 

Product Description

  
introNet (Empagliflozin), according to Mr Column by boehringer ingelheim and eli lilly company joint development of a type 2 sodium glucose transporters together (SGLT - 2, sodium - dependentglucosecotransporterChemicalbook2) inhibitors. Sglt-2 inhibitor is a novel hypoglycemic agent that reduces renal glucose reabsorption and urine glucose excretion by inhibiting expression of SGLT-2, and thus reduces plasma glucose levels. Its hypoglycemic effect is independent of β cell function and  resistance.
adhibitionIpalazine is used to improve glycemic control in 2 diabetic adults who have failed to achieve adequate glycemic control with diet and exercise. Should not be used to treat type 1 Chemicalbook diabetes, patients with elevated blood or urine ketoacidosis (diabetic ketoacidosis), patients with severe kidney injury, end-stage kidney disease, or patients on dialysis.
pharmacologic actionIn physiological environment, the kidney filters and reabsorbs glucose into the circulation system to maintain the balance of blood glucose in the body. The glucose entering the blood through the renal tubule must be coordinated by glucose cotransporter. As a form of sodium glucose and Chemicalbook transporter in glucose cotransporter, SGLT2 is a type of glucose cotransporter. Blocks glucose reabsorption in proximal convoluted tubules, reduces renal glucose reabsorption, increases urine glucose excretion, and thus reduces plasma glucose levels. The hypoglycemic effect was not dependent on β cell function and was not affected by resistance.
adverse reactionThe incidence of adverse reactions was low, with a common adverse reaction rate of 2% compared with placebo. Including fungal infection of urinary tract infection, the female reproductive system, upper respiratory tract infection, urine, blood lipid disorders (higher dose correlation of low density lipoprotein), joint Chemicalbook pain, male reproductive system fungus infection, hypoglycemia (while in accordance with the column net combination with  or when the sulfonylurea medications, increased incidence of low blood sugar), nausea. Other adverse reactions less than 2% are common in thirst (polydipsia, polydipsia), insufficient blood volume, and impaired kidney function.

Detailed Photos

 

Empagliflozin Antidiabetic Human Use Factory Price CAS 864070-44-0
 
 
 

 

Packaging & Shipping

 





 

Empagliflozin Antidiabetic Human Use Factory Price CAS 864070-44-0

After Sales Service

 
 
 
 
 
 
 
Empagliflozin Antidiabetic Human Use Factory Price CAS 864070-44-0
 
 
 

FAQ

 

1. who are we?
We are based in Hebei, China, start from 2021,sell to North America(30.00%),Northern Europe(15.00%),Central America(10.00%),Eastern Europe(10.00%),Western Europe(8.00%),Southern Europe(8.00%),Mid East(5.00%),South Asia(3.00%),South America(3.00%),Africa(3.00%),Domestic Market(2.00%),Oceania(2.00%),Southeast Asia(1.00%). There are total about 11-50 people in our office.

2. how can we guarantee quality?
Always a pre-production sample before mass production;
Always final Inspection before shipment;

3.what can you buy from us?
Chloronicotinicacid,2 3-Dichloropyridine,Choline glycerophosphate ,Nicotinamide

4. why should you buy from us not from other suppliers?
Hebei Lingding Biotechnology Co., Ltd. has always adhered to the core concept of "focus on products, attentive service", adhere to the business purpose of "innovation, professional, win-win", to provide customers with meticulous and though services.

5. what services can we provide?
Accepted Delivery Terms: FOB, CFR, CIF, EXW, Express Delivery;
Accepted Payment Currency: USD;
Accepted Payment Type: T/T, MoneyGram, Western Union ,Cash;
Language Spoken :English, Chinese
 

 

 
 
 
 
 
 
 
 

You Might Also Like